Navigation Links
Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
Date:5/3/2012

SAN DIEGO, May 3, 2012  /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today reported financial results for the first quarter ended March 31, 2012.

During the first quarter of 2012, Cadence reported net product revenue of $8.0 million, an increase of $7.6 million as compared to the first quarter of 2011. As compared to the quarter ended December 31, 2011, net product revenue for the first quarter of 2012 increased $2.1 million, or 36%, from $5.9 million.

As of March 31, 2012, approximately 2,700 unique accounts had ordered OFIRMEV® (acetaminophen) injection, an increase of approximately 20% quarter-over-quarter, and an estimated 330,000 to 410,000 patients were treated with OFIRMEV in just the first three months of 2012.

"Demand for OFIRMEV continued to grow at a strong pace in the first quarter, and I am encouraged by the underlying trends. Our customer base has increased and our customers made larger orders of the product as compared to the previous quarter," said Ted Schroeder, President and CEO of Cadence. "Our team is focused on expanding on these positive trends and driving continued adoption and revenue growth of OFIRMEV."

Cadence believes that returns related to the voluntary recall of a single lot of OFIRMEV that was announced in February 2012 have been substantially completed. While some customers experienced a short-term supply delay as a result of the temporary suspension of shipments from the supplier of the recalled lot, the company was able to accelerate the delivery of product from another supplier and quickly resumed normal shipments.

Financial ResultsNet product revenue was $8.0 million for the three months ended
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston on March 7, 2012
2. Cadence Pharmaceuticals Announces Voluntary Recall of One Lot of OFIRMEV® (Acetaminophen) Injection
3. HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical
4. Cadence Pharmaceuticals Announces Completion of Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option by Underwriters
5. Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock
6. Cadence Pharmaceuticals Reports Third Quarter 2011 Financial Results
7. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2011 Financial Results on November 3, 2011
8. Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011
9. Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results
10. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of August 2011
11. Cadence Pharmaceuticals Reaffirms FDA-Approved Dosing Recommendations for OFIRMEV® (acetaminophen) Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  MedScope ( www.medscope.org ), the leading provider of ... Connected World magazine Connected World Award for ... can be used anywhere, anytime. The nomination was made ... In nominating MedScope, Landon Garner , Director of ...
(Date:1/23/2015)... 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is ... Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... fiduciary duties to shareholders. On January 21, ... reporting that Advaxis had misrepresented the clinical data for ...
(Date:1/23/2015)... 23, 2015  Now available for sale, The Armor1 Ankle ... prevents ankle sprains by cushioning the ankle from an ... around the outside of any shoe type and allows ... still offering protection against sprains. With customers in physical ...
Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
... Reportlinker.com announces that a new market research report is ... Pharmaceutical Packaging Market http://www.reportlinker.com/p0288103/US-Pharmaceutical-Packaging-Market.html ... 5.5% annually through 2014 Demand for ... increase 5.5 percent annually to $18.4 billion in 2014. ...
... Inc. (PSI), a leading pharmaceutical Contract Research Organization ... to help advance early stage molecules and drug ... Under the established framework between Children,s and PSI, ... at progressing the specific drug or drug product ...
Cached Medicine Technology:Reportlinker Adds US Pharmaceutical Packaging Market 2Reportlinker Adds US Pharmaceutical Packaging Market 3Reportlinker Adds US Pharmaceutical Packaging Market 4Reportlinker Adds US Pharmaceutical Packaging Market 5Reportlinker Adds US Pharmaceutical Packaging Market 6Reportlinker Adds US Pharmaceutical Packaging Market 7Reportlinker Adds US Pharmaceutical Packaging Market 8Reportlinker Adds US Pharmaceutical Packaging Market 9Reportlinker Adds US Pharmaceutical Packaging Market 10Children's Hospital Boston and Particle Sciences Cooperate on Translational Medicine Efforts 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 Deer Path of ... host a Valentine’s Day Happy Hour from 3 p.m. to 4 ... 12500 Regency Parkway in Huntley, Illinois, serves adults with physical disabilities ... event will include Valentine's Day treats, games and sweetheart-themed karaoke. , ...
(Date:1/22/2015)... The City of West Hollywood hosted a news conference on ... anniversary of the Supreme Court decision Roe v. Wade, which legalized ... the Roe vs. Wade decision and the fight to protect a ... City of West Hollywood Councilmember Abbe Land. “We need to continue ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who ... are thrilled to have it lead the wedding dress industry ... of prom dresses for the global market. , “The CEO ... and he focuses on continuing the goal of operational excellence ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently ... View website of AngelWeddingDress.com to find more details. ... online for a bridal party. AngelWeddingDress offers a variety ... Its maternity wedding dresses are specially designed for 2015. ...
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo and ... federal multidistrict litigation underway in U.S. District Court, District ... Order dated January 20th, the Court has remanded a ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4
... of childhood cancer survivors who received prior treatment involving ... agents do not have an increased risk for birth ... have such cancer treatment. The findings provide reassurance that ... survivors who are concerned about the potential effects of ...
... HealthDay Reporter , MONDAY, Dec. 12 (HealthDay News) -- Young ... do not seem to face an increased risk for cardiovascular ... that these drugs can cause increases in heart rate and ... that these effects posed a risk, the researchers said. ...
... Athens, Ga.Researchers from the University of Georgia and the Mayo ... tumors in a mouse model that mimics 90 percent of ... to common treatments. The vaccine, described this ... of the National Academy of Sciences , reveals a promising ...
... December 12, 2011. Researchers from the University of Maryland ... launched a study of exercise and computerized memory training to ... prevent memory changes. The type of memory that will be ... take in information and use it in a new way. ...
... ways to halt the uncontrolled growth of cancer cells, scientists ... drugs, called PARP inhibitors, may block the ability of pre-leukemic ... these cells to self-destruct. Results of their experiments, expected ... American Society of Hematology in San Diego, Dec. 12, have ...
... 12, 2011) -- A new study finds that patients who ... twice as likely to develop delirium, a potentially dangerous change ... began their stay in isolation were not at increased risk. ... Infection Control and Hospital Epidemiology, the journal of the ...
Cached Medicine News:Health News:Childhood cancer survivors' exposure to chemotherapy, radiation does not increase risk of birth defects in their children 2Health News:Childhood cancer survivors' exposure to chemotherapy, radiation does not increase risk of birth defects in their children 3Health News:Childhood cancer survivors' exposure to chemotherapy, radiation does not increase risk of birth defects in their children 4Health News:ADHD Drugs Don't Raise Risk of Heart Problems: Study 2Health News:ADHD Drugs Don't Raise Risk of Heart Problems: Study 3Health News:Scientists develop vaccine that attacks breast cancer in mice 2Health News:Scientists develop vaccine that attacks breast cancer in mice 3Health News:Scientists develop vaccine that attacks breast cancer in mice 4Health News:Exercise/memory research for Parkinson's 2Health News:Exercise/memory research for Parkinson's 3Health News:'PARP' drug sabotages DNA repair in pre-leukemic cells 2Health News:'PARP' drug sabotages DNA repair in pre-leukemic cells 3Health News:Patient isolation associated with hospital delirium: study 2
...
...
...
Conforms to the convexity of the lens providing easier access to anterior capsule. Reduces pontential of corneal touch. 35G x 5/8in (.50 x 16mm)...
Medicine Products: